InvestorsHub Logo

Allnewsisgoodnews

02/26/19 8:34 PM

#37896 RE: JA2626 #37895

Agreed, as long as there is no competing CCR5 antibody in as advanced development, someone will want leronlimab, and fast! (Trump voice)